Trending News
News
News
Surprising Mechanism Behind Antibiotic-Resistant Bacteria Uncovered
Now, scientists at TSRI have discovered that the important human pathogen Staphylococcus aureus, develops resistance to this drug by “switching on” a previously uncharacterized set of genes.
News
SYGNIS AG Signs Non-Exclusive Distribution Agreement with GeneWorks Pty Ltd
Agreement covers the entire SYGNIS portfolio of powerful tools for next generation sequencing and single cell analysis applications.
News
AstraZeneca, Peregrine Pharmaceuticals Collaborate
Collaboration to Focus on Cancer Immunotherapy Combination of Peregrine's PS-Targeting Bavituximab and AstraZeneca's PD-L1 Inhibitor MEDI4736.
News
Medivation Acquires Talazoparib Rights from BioMarin
Under the agreement, Medivation will be responsible for all research, development, regulatory and commercialization activities for all indications on a global basis.
News
Genetic Overlapping in Multiple Autoimmune Diseases May Suggest Common Therapies
CHOP genomics expert leads analysis of genetic architecture, with eye on repurposing existing drugs.
News
MorphoSys and Immatics Enter Strategic Alliance in Immuno-oncology
Collaboration aims to develop novel antibody-based therapies targeting tumor-associated peptides derived from intracellular proteins.
News
Santhera Receives Rare Pediatric Disease Designation from FDA
FDA has granted designation for idebenone for the treatment of Duchenne Muscular Dystrophy.
News
TxCell Consortium Granted EUR 1.28 Million for TRUST Project
French Government and local authorities award grant from the FUI to the consortium composed of TxCell, Provepep, Hospital La Pitié Salpêtrière and Quinze-Vingts Hospital Center (Paris).
News
Burning Rock and Illumina Collaborate on Molecular Diagnostics for Oncology
Collaboration highlights the ever-increasing importance of genomics to improve healthcare in China.
News
RG Institute Science Challenge Winners Use Omicia Clinical Interpretation Software
Recipients will receive free access to Omicia’s Opal software in support of their ongoing research.
Advertisement